Dietary CoQ10 lowers risk of new-onset hypertension: Study


Writing in the journal Nutrientsโ€‹, Chinese researchers at Sun Yat-sen University also noted that previous animal and human studies show that CoQ10 deficiency is associated with many chronic diseases.

โ€œPrior human studies limited to small-scale short-term randomized controlled trials (RCTs) have evaluated various high doses of CoQ10 supplementation on surrogate markers of cardiovascular disease (CVD) risks, such as blood pressure,โ€ the researchers wrote. โ€œHowever, there has been no prospective investigation of the relationship between long-term dietary CoQ10 intake and new-onset hypertension in the general population of adults.โ€ย 

A notable antioxidantโ€‹

Hypertension is an increasing problem globally, and the prevalence has doubled over the last three decades. Hypertension management is key to CVD risk and related deaths.

Coenzyme Q10 (CoQ10), a substance that helps convert food into energy, is found in most cells in the body and is a notable antioxidant. CoQ10 can be supplemented or consumed from different kinds of foods.

โ€œIts principal role in the cell is to participate in the electron transport chain in the inner mitochondrial membrane, acting as a cofactor in the synthesis of ATP,โ€ the researchers explained. โ€œCoQ10 protects both mitochondrial and extra-mitochondrial cellular membranes against oxidative stress.โ€

A CoQ10 deficiency is associated with several conditions, including hypertension, diabetes and dyslipidemia. This can be addressed through supplementation but โ€œthe widespread availability of CoQ10 supplements is hindered by their high cost, posing a challenge for general population access,โ€ the researchers noted.



Source link

>